about
5-HT(6) receptor recruitment of mTOR as a mechanism for perturbed cognition in schizophreniaLost in translation: preclinical studies on 3,4-methylenedioxymethamphetamine provide information on mechanisms of action, but do not allow accurate prediction of adverse events in humansS32212, a novel serotonin type 2C receptor inverse agonist/α2-adrenoceptor antagonist and potential antidepressant: II. A behavioral, neurochemical, and electrophysiological characterization5-HT6 receptor antagonists reverse delay-dependent deficits in novel object discrimination by enhancing consolidation--an effect sensitive to NMDA receptor antagonismEffect of intrathecal proctolin administration on the behaviour evoked by the thyrotrophin-releasing hormone (TRH) analogue (RX 77368) and the indoleamine, TRH, substance P and calcitonin gene-related peptide levels and choline acetyltransferase actInvolvement of 5-HT2 receptors in the behaviours produced by intrathecal administration of selected 5-HT agonists and the TRH analogue (CG 3509) to ratsDown-Regulation of Hippocampal Genes Regulating Dopaminergic, GABAergic, and Glutamatergic Function Following Combined Neonatal Phencyclidine and Post-Weaning Social Isolation of Rats as a Neurodevelopmental Model for Schizophrenia.The preclinical pharmacology of mephedrone; not just MDMA by another name.Lentiviral delivery of a vesicular glutamate transporter 1 (VGLUT1)-targeting short hairpin RNA vector into the mouse hippocampus impairs cognitionToo little and too much: hypoactivation and disinhibition of medial prefrontal cortex cause attentional deficits.D-amphetamine and antipsychotic drug effects on latent inhibition in mice lacking dopamine D2 receptors.Animal models of schizophrenia.Modification of 5-HT2 receptor mediated behaviour in the rat by oleamide and the role of cannabinoid receptors.E-6801, a 5-HT6 receptor agonist, improves recognition memory by combined modulation of cholinergic and glutamatergic neurotransmission in the rat.Reversal of a cholinergic-induced deficit in a rodent model of recognition memory by the selective 5-HT6 receptor antagonist, Ro 04-6790.Involvement of 5-HT receptors in the regulation of food intake in Siberian hamsters.Evidence-based guidelines for management of attention-deficit/hyperactivity disorder in adolescents in transition to adult services and in adults: recommendations from the British Association for Psychopharmacology.Fos expression in the prefrontal cortex and ventral striatum after exposure to a free-operant timing schedule.Fos expression in the orbital prefrontal cortex after exposure to the fixed-interval peak procedure.Behavioural and neurochemical effects of post-weaning social isolation in rodents-relevance to developmental neuropsychiatric disorders.The antimalarial drug quinine interferes with serotonin biosynthesis and action.A role for 5-ht6 receptors in retention of spatial learning in the Morris water maze.Functional identification of 5HT receptor subtypes.Infections Up to 76 Days After Stroke Increase Disability and Death.Differential effects of cathinone compounds and MDMA on body temperature in the rat, and pharmacological characterization of mephedrone-induced hypothermia.Effect of acute brain tyrosine depletion on MDMA-induced changes in brain 5-HT.Selective blockade of dopamine D3 receptors enhances while D2 receptor antagonism impairs social novelty discrimination and novel object recognition in rats: a key role for the prefrontal cortex.Dopamine D1 receptor stimulation modulates the formation and retrieval of novel object recognition memory: Role of the prelimbic cortex.Immunohistochemical localisation of the 5-HT2C receptor protein in the rat CNS.Effect of neuropeptides on cognitive function.Role of the anterior cingulate cortex in the retrieval of novel object recognition memory after a long delay.Investigation of stretching behaviour induced by the selective 5-HT6 receptor antagonist, Ro 04-6790, in rats.Effect of chronic m-CPP on locomotion, hypophagia, plasma corticosterone and 5-HT2C receptor levels in the ratEffects of amphetamine isomers, methylphenidate and atomoxetine on synaptosomal and synaptic vesicle accumulation and release of dopamine and noradrenaline in vitro in the rat brain.The dopamine D3 receptor antagonist, S33138, counters cognitive impairment in a range of rodent and primate procedures.Translational neuropharmacology and the appropriate and effective use of animal models.Phencyclidine withdrawal disrupts episodic-like memory in rats: reversal by donepezil but not clozapine.Behavioural characterisation of the effects of acute and repeated administration of GBR 12909 in rats: further evaluation of a potential model of ADHD.The effects of pharmacological blockade of the 5-HT(6) receptor on formalin-evoked nociceptive behaviour, locomotor activity and hypothalamo-pituitary-adrenal axis activity in rats.DR4004, a putative 5-HT(7) receptor antagonist, also has functional activity at the dopamine D2 receptor.
P50
Q24299992-17893B6C-B71C-4714-BADC-EDD01B663372Q26859367-A8E60CD0-A057-450C-BACE-0049AE8F2666Q28255656-C4E1D7AE-31D1-4F12-9C5D-A012AABA3CE0Q28269069-6542CC2B-AB52-4F1F-85F1-D5E05616CE47Q28339479-315F266A-7666-487B-943D-BFAB20C28097Q28339792-143D0CED-9BA5-48C2-BA72-D530BECD116AQ30368373-715E1A7F-CADC-4F8A-BDC7-3D030A0014D5Q30412911-3F44C07E-8B5A-429C-9BC8-976FA49121EEQ30422055-BE59C54B-72C9-458A-8F5F-CE29A740928CQ30436783-CF35E646-7D23-4500-A610-4BF95A78663DQ30453020-F93DE74A-A4D2-49DD-8D85-F18776F3D087Q30462828-0B77DC3F-DAF9-455D-9225-504E3B35E1F3Q30677511-D1C200FA-CC35-4733-AAE8-3E2A25151F09Q34111024-2CE81721-0D08-4E15-8B45-8D9BDBEDAB48Q34247123-71A701F6-DCF7-4B33-A201-6D97275FA4B4Q34415764-2595B80D-E8FF-4626-98F5-27B6B83F2327Q36648476-25B4C89B-E2A2-4DDE-A846-7E32F53C9943Q36852700-F6580321-F08B-46EE-94AC-CA6EF232F728Q36852708-B8DAE477-1833-427E-A0E9-41C91BDF0C5EQ37142617-E316919C-2140-4515-B298-78DCE3CE8C00Q37453950-17AB0706-C96E-4131-9AFB-86523BD7C873Q38298172-9454AEFA-7121-4788-BA54-8A9F97327CEEQ38355717-69F76240-2E22-442D-AB4A-46260CFB182FQ38373189-AA99D859-CF64-418F-8C3A-D15ADBA2EFF4Q39970850-6089915B-F695-4D7C-A650-2F09DCD4EDBEQ40372241-A7FC98FE-4715-4338-98CB-E1A15146ABA0Q40496424-57763BD6-2344-45F3-9543-8F324FFE2934Q40638784-643B4345-BC02-41FF-9D03-B260B4C98276Q40901462-7570A45F-AB76-46F6-BFB6-F998ED1E7218Q41604656-3CEFA428-9CEB-4DE9-922C-421C77778555Q41859428-ADD65118-8EAD-4E18-B195-971210913808Q42020074-096F3E83-A821-4933-83A4-10FC50838C9AQ42043828-0BE8ED64-3880-47B8-BCFD-FD05EEAECDFDQ42502296-7A1F2334-71A5-4816-B9B2-7EBAA1880591Q42955835-B789AA8B-5B83-45B3-A661-98B606676928Q43000927-F1318C7F-608D-4398-912F-A936875E9FA6Q43126180-4E60AA14-FDBB-40C4-A1E7-88A7B4425119Q43287778-187CAA2A-2E87-49D7-A4A8-6B909EBC1D44Q43349630-5C44EA0A-38E0-46B1-BF2A-2CEE3F4F23B5Q44090404-3329A162-D943-439E-B7F7-FD68D1F8DBD1
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Kevin Fone
@ast
Kevin Fone
@en
Kevin Fone
@es
Kevin Fone
@nl
Kevin Fone
@sl
type
label
Kevin Fone
@ast
Kevin Fone
@en
Kevin Fone
@es
Kevin Fone
@nl
Kevin Fone
@sl
prefLabel
Kevin Fone
@ast
Kevin Fone
@en
Kevin Fone
@es
Kevin Fone
@nl
Kevin Fone
@sl
P106
P1153
7004559556
P21
P31
P496
0000-0001-8760-2167